BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5047141)

  • 1. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.
    Parr I
    Br J Cancer; 1972 Jun; 26(3):174-82. PubMed ID: 5047141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG therapy of pleural and peritoneal growth of transplanted rat tumours.
    Pimm MV; Baldwin RW
    Int J Cancer; 1975 Feb; 15(2):260-9. PubMed ID: 165155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunoprophylaxis and immunotherapy in two mouse lymphoma models.
    Ghose T; Guclu A; Tai J; Norvell ST; MacDonald AS
    J Natl Cancer Inst; 1976 Aug; 57(2):303-15. PubMed ID: 794497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-associated transplantation antigens of neoplasms induced by a naturally occurring murine sarcoma virus (FBJ-MSV).
    Jones DB; Moore M
    Br J Cancer; 1973 Jun; 27(6):415-26. PubMed ID: 4516007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice.
    Vyakarnam A; Lachmann PJ; Sikora K
    Immunology; 1981 Feb; 42(2):337-48. PubMed ID: 6161889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprophylaxis and immunotherapy of EL4 lymphoma.
    Ghose T; Guclu A; Tai J; Mammen M; Norvell ST
    Eur J Cancer (1965); 1977 Sep; 13(9):925-35. PubMed ID: 913475
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour inhibition mediated by BCG in immunosuppressed rats.
    Moore M; Lawrence N; Nisbet NW
    Int J Cancer; 1975 Jun; 15(6):897-911. PubMed ID: 1150345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastic capacity.
    Davey GC; Currie GA; Alexander P
    Br J Cancer; 1976 Jan; 33(1):9-14. PubMed ID: 1252330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal cell populations during tumour injection.
    De Heer E; De Groot JW; Den Otter W; Dullens HF
    Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength.
    Fiszer-Maliszewska L; Den Otter W; Mordarski M
    Cancer Immunol Immunother; 1999 Feb; 47(6):307-14. PubMed ID: 10203060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA.
    Parr I; Wheeler E; Alexander P
    Br J Cancer; 1973 May; 27(5):370-89. PubMed ID: 4713170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempts to induce a graft-versus-tumour reaction against AKR lymphomata, in isogenic mice, by injection of Melphalan and foreign immunologically competent cells.
    Denton PM; Symes MO
    Br J Cancer; 1969 Mar; 23(1):95-102. PubMed ID: 5768449
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of a herpesvirus-transformed hamster cell line: immunogenicity of sublines of high and low metastatic potential.
    Teale DM; Rees RC; Clark A; Potter CW
    Int J Cancer; 1984 May; 33(5):701-8. PubMed ID: 6724744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of BCG on B16 mouse melanoma: a comparison of routes of administration on tumour growth at different anatomical sites.
    Proctor JW; Auclair BG; Lewis MG
    Eur J Cancer (1965); 1976 Mar; 12(3):203-10. PubMed ID: 939237
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.
    Forni G; Comoglio PM
    Br J Cancer; 1974 Oct; 30(4):365-9. PubMed ID: 4447779
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection against transplanted and spontaneous lymphoma by inoculation of heat-altered syngeneic tumor cells in splenectomized mice.
    Check JH; Brady LW; Leipold PL; O'Neill EA
    Cancer; 1974 Jul; 34(1):197-203. PubMed ID: 4834179
    [No Abstract]   [Full Text] [Related]  

  • 17. [An attempt to control the growth of syngeneic experimental tumors in inbred mice using Listeria factor Ei, BCG vaccine and a combination of both].
    Zák M; Mára M; Jirkovský J
    Sb Lek; 1989 Sep; 91(8):230-7. PubMed ID: 2617123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic changes in cultured murine lymphomas after retransplantation into syngeneic hosts.
    Cikes M
    J Natl Cancer Inst; 1975 Apr; 54(4):903-6. PubMed ID: 1127719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with irradiated tumour cells and BCG in experimental osteosarcoma.
    Larsson SE; Lorentzon R; Boquist L
    Acta Orthop Scand; 1981 Oct; 52(5):469-74. PubMed ID: 6949451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of "lymphotoxin" in the local anti-tumour action associated with inflammation caused by delayed hypersensitivity responses or intralesional BCG. I. Variations in response of different syngeneic mouse tumours.
    Parr IB; Jackson LE; Alexander P
    Br J Cancer; 1983 Sep; 48(3):395-403. PubMed ID: 6604535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.